Endocrine, reproductive, and cardiovascular drugs
Endocrine, Reproductive, and Cardiovascular Drugs
Complete the subjoined and surrender your answers.
· Chapter 23, page 470, Case Study B- Antidiabetic Agents and page 471, questions 1 through 10.
· Chapter 25, page 494, questions 1 through 10.
Chapter 23, page 470, Case Study B – Antidiabetic Drugs
1. The physician starts him on glyburide, a sulfonylurea medication. He explains to Marcus that sulfonylureas employment by:
2. The physician explains to Marcus that one of the plane consequences of a sulfonylurea medication is:
3. Prior to prescribing the medication, the physician reviews Marcus’s medical fact. This is accordingly sulfonylureas must be used delay terminal inadventurousness in individual’s who:
4. The physician inadventurousnesss Marcus to overcome him preceding to preliminary any other medication accordingly of practicable interactions. Which garbage can potentiate the hypoglycemic consequence of a sulfonylurea?
5. What garbage causes an interresuscitation delay sulfonylureas, resulting in hostile resuscitation in which a larger dose may be required?
Antidiabetic Agents and page 471, questions 1 through 10.
1. Glucophage – Oral antidiabetic agent
2. prednisone - Corticosteroid
3. Humulin R - Insulin: incomplete acting
4. Synthroid – Thyroid agent
5. Avandia - Oral antidiabetic agent
6. Tapazole – Antithyroid
7. Isophane - Insulin: moderate acting
8. Prandin - Oral antidiabetic agent
9. Lantus – Insulin: covet acting
10. Humalog – Insulin: flying acting
Chapter 25, page 494 (in-effect pg. 541), questions 1 through 10
1. isosorbide - Angina
2. Zetia – Elevated cholesterol
3. Lovenox – Pulmonary emboli
4. Cardizem – Hypertension
5. Zocor – Elevated cholesterol
6. Plavix – Stroke obstruction (platelet inhibitor)
7. Crestor – Elevated cholesterol
8. hydralazine – Hypertension
9. quinidine – Cardiac arrhythmia
10. procainamide - Cardiac arrhythmia